Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chee Khoon Lee

Showing results (51-60 of 86) with videos related to

Pageof 9
Sort By:
Pancreas|June 17, 2020
Nomogram for Estimating Overall Survival in Patients With Metastatic Pancreatic CancerDavid Goldstein, Daniel D Von Hoff, E Gabriela Chiorean, et al.
British Journal of Cancer|December 14, 2023
Discordance between GCIG CA-125 progression and RECIST progression in the CALYPSO trial of patients with platinum-sensitive recurrent ovarian cancerDanka Sinikovic Zebic, Angelina Tjokrowidjaja, Katherine Elizabeth Francis, et al.
European Journal of Cancer (Oxford, England : 1990)|July 7, 2019
Development and validation of a prognostic nomogram for overall survival in patients with platinum-resistant ovarian cancer treated with chemotherapyChee Khoon Lee, Rebecca Asher, Michael Friedlander, et al.
Gynecologic Oncology|October 5, 2014
Impact of secondary cytoreductive surgery on survival in patients with platinum sensitive recurrent ovarian cancer: analysis of the CALYPSO trialChee Khoon Lee, Sarah Lord, Tami Grunewald, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2016
Serum Human Epidermal Growth Factor 2 Extracellular Domain as a Predictive Biomarker for Lapatinib Treatment Efficacy in Patients With Advanced Breast CancerChee Khoon Lee, Lucy Davies, Val J Gebski, et al.
Cancer|March 19, 2021
Molecular and clinical predictors of improvement in progression-free survival with maintenance PARP inhibitor therapy in women with platinum-sensitive, recurrent ovarian cancer: A meta-analysisChee Khoon Lee, Michael L Friedlander, Angelina Tjokrowidjaja, et al.
International Journal of Cancer|June 14, 2025
Optimizing management of stage IV EGFR mutant non-small cell lung cancer in Asia: An expert opinionGee-Chen Chang, Akhil Kapoor, Chee Khoon Lee, et al.
JAMA Oncology|June 15, 2018
Association of Somatic Driver Alterations With Prognosis in Postmenopausal, Hormone Receptor-Positive, HER2-Negative Early Breast Cancer: A Secondary Analysis of the BIG 1-98 Randomized Clinical TrialStephen J Luen, Rebecca Asher, Chee Khoon Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 2, 2014
Patient-reported outcome results from the open-label phase III AURELIA trial evaluating bevacizumab-containing therapy for platinum-resistant ovarian cancerMartin R Stockler, Felix Hilpert, Michael Friedlander, et al.
British Journal of Cancer|June 26, 2023
A signal-seeking Phase 2 study of olaparib and durvalumab in advanced solid cancers with homologous recombination repair gene alterationsSubotheni Thavaneswaran, Maya Kansara, Frank Lin, et al.
Pageof 9

Showing results (51-60 of 86) with videos related to

Sort By:
Pageof 9
Pancreas|June 17, 2020
Nomogram for Estimating Overall Survival in Patients With Metastatic Pancreatic CancerDavid Goldstein, Daniel D Von Hoff, E Gabriela Chiorean, et al.
British Journal of Cancer|December 14, 2023
Discordance between GCIG CA-125 progression and RECIST progression in the CALYPSO trial of patients with platinum-sensitive recurrent ovarian cancerDanka Sinikovic Zebic, Angelina Tjokrowidjaja, Katherine Elizabeth Francis, et al.
European Journal of Cancer (Oxford, England : 1990)|July 7, 2019
Development and validation of a prognostic nomogram for overall survival in patients with platinum-resistant ovarian cancer treated with chemotherapyChee Khoon Lee, Rebecca Asher, Michael Friedlander, et al.
Gynecologic Oncology|October 5, 2014
Impact of secondary cytoreductive surgery on survival in patients with platinum sensitive recurrent ovarian cancer: analysis of the CALYPSO trialChee Khoon Lee, Sarah Lord, Tami Grunewald, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2016
Serum Human Epidermal Growth Factor 2 Extracellular Domain as a Predictive Biomarker for Lapatinib Treatment Efficacy in Patients With Advanced Breast CancerChee Khoon Lee, Lucy Davies, Val J Gebski, et al.
Cancer|March 19, 2021
Molecular and clinical predictors of improvement in progression-free survival with maintenance PARP inhibitor therapy in women with platinum-sensitive, recurrent ovarian cancer: A meta-analysisChee Khoon Lee, Michael L Friedlander, Angelina Tjokrowidjaja, et al.
International Journal of Cancer|June 14, 2025
Optimizing management of stage IV EGFR mutant non-small cell lung cancer in Asia: An expert opinionGee-Chen Chang, Akhil Kapoor, Chee Khoon Lee, et al.
JAMA Oncology|June 15, 2018
Association of Somatic Driver Alterations With Prognosis in Postmenopausal, Hormone Receptor-Positive, HER2-Negative Early Breast Cancer: A Secondary Analysis of the BIG 1-98 Randomized Clinical TrialStephen J Luen, Rebecca Asher, Chee Khoon Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 2, 2014
Patient-reported outcome results from the open-label phase III AURELIA trial evaluating bevacizumab-containing therapy for platinum-resistant ovarian cancerMartin R Stockler, Felix Hilpert, Michael Friedlander, et al.
British Journal of Cancer|June 26, 2023
A signal-seeking Phase 2 study of olaparib and durvalumab in advanced solid cancers with homologous recombination repair gene alterationsSubotheni Thavaneswaran, Maya Kansara, Frank Lin, et al.
Pageof 9